vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $24.0M, roughly 1.9× SIFCO INDUSTRIES INC). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -19.9%, a 27.4% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 14.8%). SIFCO INDUSTRIES INC produced more free cash flow last quarter ($8.0M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 8.1%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
ABCL vs SIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $24.0M |
| Net Profit | $-8.9M | $1.8M |
| Gross Margin | — | 21.6% |
| Operating Margin | -63.7% | 10.7% |
| Net Margin | -19.9% | 7.5% |
| Revenue YoY | 788.4% | 14.8% |
| Net Profit YoY | 73.9% | 177.3% |
| EPS (diluted) | $-0.03 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $24.0M | ||
| Q3 25 | $9.0M | $22.8M | ||
| Q2 25 | $17.1M | $22.1M | ||
| Q1 25 | $4.2M | $19.0M | ||
| Q4 24 | $5.0M | $20.9M | ||
| Q3 24 | $6.5M | $21.7M | ||
| Q2 24 | $7.3M | $22.0M | ||
| Q1 24 | $10.0M | $20.5M |
| Q4 25 | $-8.9M | $1.8M | ||
| Q3 25 | $-57.1M | $-429.0K | ||
| Q2 25 | $-34.7M | $3.4M | ||
| Q1 25 | $-45.6M | $-1.4M | ||
| Q4 24 | — | $-2.3M | ||
| Q3 24 | $-51.1M | $-443.0K | ||
| Q2 24 | $-36.9M | $72.0K | ||
| Q1 24 | $-40.6M | $-1.6M |
| Q4 25 | — | 21.6% | ||
| Q3 25 | — | 9.6% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | -63.7% | 10.7% | ||
| Q3 25 | -851.8% | -1.7% | ||
| Q2 25 | -290.2% | 14.8% | ||
| Q1 25 | -1479.6% | -4.1% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | -1439.4% | -1.5% | ||
| Q2 24 | -1276.2% | 0.7% | ||
| Q1 24 | -551.5% | -6.5% |
| Q4 25 | -19.9% | 7.5% | ||
| Q3 25 | -637.8% | -1.9% | ||
| Q2 25 | -203.3% | 15.4% | ||
| Q1 25 | -1077.2% | -7.3% | ||
| Q4 24 | — | -11.1% | ||
| Q3 24 | -785.4% | -2.0% | ||
| Q2 24 | -504.3% | 0.3% | ||
| Q1 24 | -408.0% | -7.8% |
| Q4 25 | $-0.03 | $0.29 | ||
| Q3 25 | $-0.19 | $-0.07 | ||
| Q2 25 | $-0.12 | $0.56 | ||
| Q1 25 | $-0.15 | $-0.23 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | $-0.17 | $-0.07 | ||
| Q2 24 | $-0.13 | $0.01 | ||
| Q1 24 | $-0.14 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $1.1M |
| Total DebtLower is stronger | — | $39.0K |
| Stockholders' EquityBook value | $966.9M | $38.7M |
| Total Assets | $1.4B | $74.9M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $1.1M | ||
| Q3 25 | $83.2M | $491.0K | ||
| Q2 25 | $92.4M | $2.0M | ||
| Q1 25 | $159.3M | $1.9M | ||
| Q4 24 | $156.3M | $3.1M | ||
| Q3 24 | $126.6M | $1.7M | ||
| Q2 24 | $148.3M | $3.4M | ||
| Q1 24 | $123.6M | $2.5M |
| Q4 25 | — | $39.0K | ||
| Q3 25 | — | $51.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $4.1M |
| Q4 25 | $966.9M | $38.7M | ||
| Q3 25 | $964.0M | $36.9M | ||
| Q2 25 | $1.0B | $35.8M | ||
| Q1 25 | $1.0B | $32.4M | ||
| Q4 24 | $1.1B | $33.7M | ||
| Q3 24 | $1.1B | $30.4M | ||
| Q2 24 | $1.1B | $29.8M | ||
| Q1 24 | $1.1B | $29.7M |
| Q4 25 | $1.4B | $74.9M | ||
| Q3 25 | $1.4B | $73.4M | ||
| Q2 25 | $1.4B | $77.3M | ||
| Q1 25 | $1.3B | $78.8M | ||
| Q4 24 | $1.4B | $81.0M | ||
| Q3 24 | $1.4B | $104.6M | ||
| Q2 24 | $1.4B | $106.3M | ||
| Q1 24 | $1.5B | $104.2M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $8.1M |
| Free Cash FlowOCF − Capex | $-44.6M | $8.0M |
| FCF MarginFCF / Revenue | -99.4% | 33.3% |
| Capex IntensityCapex / Revenue | 21.9% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $8.1M | ||
| Q3 25 | $-52.6M | $726.0K | ||
| Q2 25 | $-32.4M | $371.0K | ||
| Q1 25 | $-11.6M | $2.8M | ||
| Q4 24 | $-108.6M | $-3.8M | ||
| Q3 24 | $-28.9M | $857.0K | ||
| Q2 24 | $-30.0M | $382.0K | ||
| Q1 24 | $-41.7M | $-3.2M |
| Q4 25 | $-44.6M | $8.0M | ||
| Q3 25 | $-61.5M | $566.0K | ||
| Q2 25 | $-45.8M | $310.0K | ||
| Q1 25 | $-22.2M | $2.7M | ||
| Q4 24 | $-187.0M | $-3.9M | ||
| Q3 24 | $-47.4M | $580.0K | ||
| Q2 24 | $-50.1M | $-175.0K | ||
| Q1 24 | $-65.8M | $-3.9M |
| Q4 25 | -99.4% | 33.3% | ||
| Q3 25 | -687.0% | 2.5% | ||
| Q2 25 | -267.9% | 1.4% | ||
| Q1 25 | -524.0% | 14.1% | ||
| Q4 24 | -3702.8% | -18.8% | ||
| Q3 24 | -728.4% | 2.7% | ||
| Q2 24 | -683.8% | -0.8% | ||
| Q1 24 | -661.5% | -18.9% |
| Q4 25 | 21.9% | 0.4% | ||
| Q3 25 | 99.7% | 0.7% | ||
| Q2 25 | 78.2% | 0.3% | ||
| Q1 25 | 251.1% | 0.8% | ||
| Q4 24 | 1552.7% | 0.5% | ||
| Q3 24 | 284.6% | 1.3% | ||
| Q2 24 | 274.6% | 2.5% | ||
| Q1 24 | 242.5% | 3.3% |
| Q4 25 | — | 4.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
